<ARTICLE> 5
<LEGEND>
Regeneron Pharmaceuticals, Inc. Exhibit 27 December 31, 1998 Form 10-K (in
thousands, except share data)
</LEGEND>
<MULTIPLIER> 1000
       
                             
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          19,757
<SECURITIES>                                    93,773
<RECEIVABLES>                                    5,710
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                92,901
<PP&E>                                          59,631
<DEPRECIATION>                                  26,612
<TOTAL-ASSETS>                                 156,915
<CURRENT-LIABILITIES>                            9,402
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            27
<OTHER-SE>                                     131,200
<TOTAL-LIABILITY-AND-EQUITY>                   156,915
<SALES>                                              0
<TOTAL-REVENUES>                                45,193
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                53,390
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 428
<INCOME-PRETAX>                                 (8,625)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (8,625)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (8,625)
<EPS-PRIMARY>                                    (0.28)
<EPS-DILUTED>                                    (0.28)